Park, N.; Cho, Y.; Zheng, H.-M.; Ryu, W.K.; Jung, K.H.; Lim, J.H.
Revisiting Biomarker-Guided Therapy in EGFR-Mutant Non-Small Cell Lung Cancer with High PD-L1 Expression. Int. J. Mol. Sci. 2026, 27, 3294.
https://doi.org/10.3390/ijms27073294
AMA Style
Park N, Cho Y, Zheng H-M, Ryu WK, Jung KH, Lim JH.
Revisiting Biomarker-Guided Therapy in EGFR-Mutant Non-Small Cell Lung Cancer with High PD-L1 Expression. International Journal of Molecular Sciences. 2026; 27(7):3294.
https://doi.org/10.3390/ijms27073294
Chicago/Turabian Style
Park, Nuri, Yejin Cho, Hong-Mei Zheng, Woo Kyung Ryu, Kyung Hee Jung, and Jun Hyeok Lim.
2026. "Revisiting Biomarker-Guided Therapy in EGFR-Mutant Non-Small Cell Lung Cancer with High PD-L1 Expression" International Journal of Molecular Sciences 27, no. 7: 3294.
https://doi.org/10.3390/ijms27073294
APA Style
Park, N., Cho, Y., Zheng, H.-M., Ryu, W. K., Jung, K. H., & Lim, J. H.
(2026). Revisiting Biomarker-Guided Therapy in EGFR-Mutant Non-Small Cell Lung Cancer with High PD-L1 Expression. International Journal of Molecular Sciences, 27(7), 3294.
https://doi.org/10.3390/ijms27073294